Advertisement
Advertisement
APUS
A
Apimeds Pharmaceuticals US, Inc.
1.51
USDSponsored
+0.06
+4.38%
May 08, 15:29 UTC -4
Closed
After-Market
1.41
-0.11
-7.17%
Apimeds Pharmaceuticals US, Inc. Financial Snapshot
| Market Cap | 17.67M |
| Beta | -- |
| Earnings Per Share (EPS) | -- |
| Price-to-Book (P/B) Ratio | 2.90 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 6.13% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -139.57% |
| Current Ratio | 8.34% |
| Free Cash Flow | -5.14M |
Trending Stocks
Advertisement